Dabrafenib–trametinib moves to the first line in low-grade glioma
Crossref DOI link: https://doi.org/10.1038/s41571-023-00829-z
Published Online: 2023-10-10
Published Print: 2023-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2023-10-10
Version of Record valid from 2023-10-10
Article History
First Online: 10 October 2023